BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 8556099)

  • 1. Neuroleptic malignant syndrome associated with clozapine treatment.
    Tsai G; Crisostomo G; Rosenblatt ML; Stern TA
    Ann Clin Psychiatry; 1995 Jun; 7(2):91-5. PubMed ID: 8556099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome and clozapine.
    Reddig S; Minnema AM; Tandon R
    Ann Clin Psychiatry; 1993 Mar; 5(1):25-7. PubMed ID: 8102300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rechallenging clozapine after neuroleptic malignant syndrome.
    Anbalagan E; Ithman M; Lauriello J
    Psychiatr Q; 2014 Sep; 85(3):345-8. PubMed ID: 24633526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
    World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine-induced neuroleptic malignant syndrome: review and report of new cases.
    Sachdev P; Kruk J; Kneebone M; Kissane D
    J Clin Psychopharmacol; 1995 Oct; 15(5):365-71. PubMed ID: 8830069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature.
    Karagianis JL; Phillips LC; Hogan KP; LeDrew KK
    Ann Pharmacother; 1999 May; 33(5):623-30. PubMed ID: 10369628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS.
    Illing M; Ancill R
    Can J Psychiatry; 1996 May; 41(4):258. PubMed ID: 8726793
    [No Abstract]   [Full Text] [Related]  

  • 9. Clozapine Rechallenge Following Neuroleptic Malignant Syndrome: A Systematic Review.
    Lally J; McCaffrey C; OʼMurchu C; Krivoy A; Guerandel A; MacCabe JH; Gaughran F
    J Clin Psychopharmacol; 2019; 39(4):372-379. PubMed ID: 31205196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.
    Tseng PT; Chang YC; Chang CH; Wang HY; Cheng YS; Wu CK; Chen YW; Chung W
    Int J Psychiatry Med; 2015; 49(1):35-43. PubMed ID: 25838319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of clozapine-induced neuroleptic malignant syndrome.
    Miller DD; Sharafuddin MJ; Kathol RG
    J Clin Psychiatry; 1991 Mar; 52(3):99-101. PubMed ID: 1672311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
    Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suspected neuroleptic malignant syndrome in a patient receiving clozapine.
    Ganelin L; Lichtenberg PS; Marcus EL; Munter RG
    Ann Pharmacother; 1996 Mar; 30(3):248-50. PubMed ID: 8833560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine rechallenge after an episode of 'neuroleptic malignant syndrome'.
    Weller M; Kornhuber J
    Br J Psychiatry; 1992 Dec; 161():855-6. PubMed ID: 1362370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome and atypical antipsychotic drugs.
    Ananth J; Parameswaran S; Gunatilake S; Burgoyne K; Sidhom T
    J Clin Psychiatry; 2004 Apr; 65(4):464-70. PubMed ID: 15119907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?].
    Weller M; Kornhuber J
    Fortschr Neurol Psychiatr; 1993 Jun; 61(6):217-22. PubMed ID: 8330832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome during low dosed neuroleptic medication in first-episode psychosis: a case report.
    Gönner F; Baumgartner R; Schüpbach D; Merlo MC
    Psychopharmacology (Berl); 1999 Jun; 144(4):416-8. PubMed ID: 10435416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].
    Erol A; Putgül G; Sert E; Mete L
    Turk Psikiyatri Derg; 2013; 24(2):140-4. PubMed ID: 23754268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical neuroleptic malignant syndrome with long-term clozapine.
    Corallo CE; Ernest D
    Crit Care Resusc; 2007 Dec; 9(4):338-40. PubMed ID: 18052897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine-induced neuroleptic malignant syndrome.
    DasGupta K; Young A
    J Clin Psychiatry; 1991 Mar; 52(3):105-7. PubMed ID: 2005072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.